Competitive intelligence on
small-molecule drugs and
the 80,000 global patents
covering them

Start your free trial now

No commitment — No credit card required

DrugPatentWatch Archives

You are currently viewing the 2004 archives
Click here to return to the current data set

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: CETRORELIX

« Back to Dashboard

Summary for Generic Name: CETRORELIX

Tradenames:1
Patents:3
Applicants:1
NDAs:1
Drug Master File Entries: see list1
Suppliers: see list1

Clinical Trials for: CETRORELIX

Cetrorelix Pamoate IM Regimens in Patients With Symptomatic Benign Prostatic Hyperplasia (BPH)
Status: Completed Condition: Benign Prostatic Hypertrophy

Cetrorelix Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Status: Terminated Condition: Benign Prostatic Hypertrophy

Analysis of Two Therapeutic With Cetrotide® in Polycystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART)
Status: Completed Condition: Polycystic Ovarian Syndrome

An Observational Study of Cetrotide® Gonadotropin-releasing Hormone Antagonist (GnRH Antagonist) With GONAL-f® in Assisted Reproductive Technologies (ART)
Status: Completed Condition: Infertility

A Study to Compare the Safety and Efficacy of Cetrotide® 3 Milligram (mg) Versus Antagon™ in Women Undergoing Ovarian Stimulation
Status: Completed Condition: Infertile Women Undergoing Assisted Reproductive Technology (ART)

Cetrotide Treatment Optimization
Status: Terminated Condition: In Vitro Fertilization; Intracytoplasmic Sperm Injection

Cetrorelix Pamoate in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Status: Completed Condition: Benign Prostatic Hypertrophy

The Role of Cetrotide Acetate in Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in Oocyte Donors
Status: Completed Condition: Ovarian Hyperstimulation Syndrome

A Multinational, Randomized, Double-Blind, Placebo‑Controlled, Parallel Group Study to Investigate the Efficacy, Safety and Duration of Effect of a Single Administration of Various Doses of Cetrorelix SR in Subjects With Histologically Confirmed Endometriosis
Status: Completed Condition: Endometriosis

Clinical Pharmacological Study of GnRH Antagonist, Cetrorelix for Healthy Female Volunteer
Status: Completed Condition: Premenopause

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Exclusivity Expiration
Serono Inc
CETROTIDE
cetrorelix
INJECTABLE; INJECTION021197Aug 11, 2000RXYes6,319,192<disabled><disabled>
Serono Inc
CETROTIDE
cetrorelix
INJECTABLE; INJECTION021197Aug 11, 2000RXYes<disabled><disabled>
Serono Inc
CETROTIDE
cetrorelix
INJECTABLE; INJECTION021197Aug 11, 2000RXYes5,198,533<disabled><disabled>
Serono Inc
CETROTIDE
cetrorelix
INJECTABLE; INJECTION021197Aug 11, 2000RXYes4,800,191<disabled><disabled>
This preview shows a limited data set
Subscribe for full access , or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc